Menta Capital’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-8,952
Closed -$442K 533
2019
Q1
$442K Sell
8,952
-2,252
-20% -$102K 0.19% 199
2018
Q4
$485K Buy
11,204
+1,031
+10% +$51.4K 0.18% 166
2018
Q3
$577K Sell
10,173
-3,861
-28% -$203K 0.2% 158
2018
Q2
$708K Buy
14,034
+3,840
+38% +$200K 0.17% 236
2018
Q1
$508K Buy
+10,194
New +$479K 0.11% 333
2017
Q4
Sell
-50,368
Closed -$1.5M 703
2017
Q3
$1.5M Sell
50,368
-30,966
-38% -$945K 0.22% 135
2017
Q2
$2.7M Sell
81,334
-35,900
-31% -$1.13M 0.32% 58
2017
Q1
$3.47M Sell
117,234
-8,430
-7% -$230K 0.34% 61
2016
Q4
$3.12M Buy
125,664
+86,083
+217% +$1.96M 0.26% 88
2016
Q3
$893K Sell
39,581
-8,700
-18% -$204K 0.09% 401
2016
Q2
$1.15M Sell
48,281
-5,961
-11% -$143K 0.16% 199
2016
Q1
$1.29M Buy
54,242
+36,200
+201% +$885K 0.18% 131
2015
Q4
$502K Buy
+18,042
New +$453K 0.06% 488
2015
Q3
Sell
-12,260
Closed -$315K 737
2015
Q2
$315K Sell
12,260
-11,640
-49% -$295K 0.05% 509
2015
Q1
$603K Sell
23,900
-5,800
-20% -$141K 0.08% 396
2014
Q4
$706K Sell
29,700
-6,400
-18% -$142K 0.1% 337
2014
Q3
$710K Buy
+36,100
New +$743K 0.12% 278

Other funds holding GMED

Menta Capital's GMED Position: Q2 2019 in Review

Menta Capital sold out of Globus Medical (GMED) in Q2 2019, closing a stake of 8,952 shares — an estimated $442K sold.

Menta Capital first reported a position in GMED in Q3 2014 and held it in 17 quarters. The position peaked at $3.47M in Q1 2017. 259 funds tracked by Wall St. Rank hold GMED as of Q2 2019.

  • Menta Capital reported no remaining Globus Medical position as of Q2 2019 after selling out during the quarter.
  • Menta Capital sold 8,952 Globus Medical shares in Q2 2019, an estimated $442K.
  • Menta Capital first reported a position in Globus Medical in Q3 2014 and held it in 17 quarters.
  • Menta Capital's Globus Medical position peaked at $3.47M in Q1 2017.
  • 259 funds tracked by Wall St. Rank held Globus Medical as of Q2 2019.

Based on Menta Capital's 13F filing for Q2 2019, filed 7 Aug 2019.